greeksoup/ stock research
Stock research / United States / MYGN / Planned sales

Myriad Genetics Inc. planned insider sales

In the last twelve months insiders at Myriad Genetics Inc. filed 1 Form 144 notice of planned sales, 15,000 shares worth $68,850 at the time of filing, from 1 seller. The latest, filed 8 June 2026: Kumar Rashmi (director), 15,000 shares worth $68,850, planned for around 8 June 2026 through Fidelity Brokerage Services LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
8 June 2026Kumar RashmiDirector15,000$68,8508 June 202615,000 shares from 8 June 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?